Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC4A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NDUFV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPH7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBB4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4707 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACAA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORA64 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUFM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2AFY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PITRM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on